Journal Article

Japanese encephalitis vaccination in pregnancy among U.S. active duty military women

Khodr, Zeina G., Hall, Clinton, Gumbs, Gia R., Conlin, Ava Marie S., Bukowinski, Anna T., Chang, Richard N.

2020

Overview

•This is the first observational cohort study to assess JE vaccination in pregnancy.•JE vaccination in pregnancy was not associated with select reproductive outcomes.•Results are similar to animal models; risk from inactivated vaccines is unlikely.•These findings are reassuring for pregnant travelers to JE endemic regions. Japanese encephalitis (JE) vaccine is an inactivated vaccine that has shown no risks in pregnancy in animal models, but epidemiologic studies are lacking. U.S. military service members located in JE endemic regions are required to be vaccinated; understanding the potential adverse events (AEs), including AEs that may occur in pregnancy, is needed. Here, we assessed pregnancy and infant health outcomes in association with JE vaccination in pregnancy. The study population consisted of 192,570 pregnancies to active duty women (2003–2014), captured in the Department of Defense Birth and Infant Health Research program. JE vaccine in pregnancy, vaccine count, formulation, trimester, and whether first career dose coincided with pregnancy were compared with unexposed pregnancies to assess risk of pregnancy and infant health outcomes. Adjusted risk estimates and 95% confidence intervals (CIs) were calculated by multivariable models. Of the 192,570 identifed pregnancies, 513 were exposed to the JE vaccine; 474 exposures occurred in the first trimester. For all outcomes, elevated risk estimates ranging from 1.53 to 1.70, were observed with receipt of >1 JE vaccine in pregnancy, though 95% CIs were wide and encompassed the null. First dose of JE vaccination in pregnancy was associated with a 1.87 (95% CI: 1.12–3.13) times increased risk of low birthweight (LBW) when excluding pregnancies exposed to other non-routinely recommended vaccinations in pregnancy. All other associations were null in both main and subset analyses. The overall results of these analyses provide reassuring findings for the safety of JE vaccination in pregnancy. Higher counts of JE vaccine received in pregnancy yielded large yet non-statistically significant risk estimates for all outcomes, though likely driven by lack of pregnancy awareness. An association was observed with LBW in subset analyses, but it was limited to women receiving their first JE vaccine and not observed in the larger main analyses.

• Publisher: Elsevier Ltd,Elsevier Limited
• Subject: Allergy and Immunology / Animal models / Animals / Armed forces / Babies / Birth defects / Birth weight / Careers / Codes / Confidence intervals / Defense programs / Eclampsia / Encephalitis / Encephalitis, Japanese - epidemiology / Encephalitis, Japanese - prevention & control / Epidemiology / Estimates / Exposure / Female / Generalized linear models / Guillain-Barre syndrome / Hispanic people / Humans / inactivated vaccines / Infant / Infant health outcomes / Infants / Japanese encephalitis vaccination / Japanese Encephalitis Vaccines - adverse effects / low birth weight / Medical coding / Medical research / Military / Military Personnel / Population / Population studies / Preeclampsia / Pregnancy / Reproductive health outcomes / research programs / risk / Risk assessment / Statistical analysis / Travel / U.S. military / Vaccination / Vaccines / Vaccines in pregnancy / Vaccines, Inactivated / Vector-borne diseases / Womens health